Introduction

In the main there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems. The difference between success and failure is how we, as medicinal chemists, tackle and resolve the problems. The meeting will include: • Live webcast for RSC-BMCS members only • Full sound and vision recording for internet upload (RSC-BMCS members only) • Wine mixer at the end of the day

Deadlines

• Feb 10 2016
  Bursary application deadline

  

Useful links

• Further event details More information about the event

Downloads

• Venue location map
• Final announcement
• Registration form
• Bursary application form

Speakers

• Mike Hann GlaxoSmithKline, United Kingdom

  http://www.rsc.org
• David Lathbury Astute Chemical Development Consulting, United Kingdom

  http://www.rsc.org
• Chris McGuigan University of Cardiff, United Kingdom

  http://www.rsc.org
• Peter Grootenhuis Vertex, United States

  http://www.rsc.org
• Miles Congreve Heptares Therapeutics, United Kingdom

  http://www.rsc.org
• Andy Barker Independent scientific consultant, United Kingdom

---

Sponsorship & supporting organisations

---

Sponsors

University of Huddersfield

Vertex

GlaxoSmithKline

AstraZeneca

Venue

3M Buckley Innovation Centre

3M Buckley Innovation Centre, University of Huddersfield, Firth Street, Huddersfield, HD1 3BD, United Kingdom

Useful links

• Venue information More information about the venue

Committee

• Nadia Ahmad Vertex, United Kingdom
• Dave Alker Dave Alker Associates, United Kingdom
• Sir Simon Campbell CBE Scientific Consultant, United Kingdom
• Gordon Saxty (co-chairman) Fidelta, Croatia
• Joe Sweeney (co-chairman) University of Huddersfield, United Kingdom

---

Organised by

RSC-BMCS

Contact information

Mrs Maggi Churchouse
Maggi Churchouse Events
3 East Barn
Market Weston Road
Thelnetham
Diss IP22 1JJ
UK
01359 221004
Contact us by email

---